Kistler-Tiffany Companies, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kistler-Tiffany Companies, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$4,702
+12.1%
1000.0%0.00%0.0%
Q1 2023$4,196
+10.0%
1000.0%0.00%0.0%
Q4 2022$3,814
-4.6%
1000.0%0.00%0.0%
Q3 2022$4,000
+33.3%
1000.0%0.00%0.0%
Q2 2022$3,0000.0%1000.0%0.00%0.0%
Q1 2022$3,000
-25.0%
1000.0%0.00%0.0%
Q4 2021$4,0000.0%1000.0%0.00%0.0%
Q3 2021$4,000
-33.3%
1000.0%0.00%0.0%
Q2 2021$6,000
-14.3%
1000.0%0.00%
-50.0%
Q1 2021$7,000
-22.2%
1000.0%0.00%
-33.3%
Q4 2020$9,000
+50.0%
1000.0%0.00%
+50.0%
Q3 2020$6,000
+50.0%
1000.0%0.00%
+100.0%
Q2 2020$4,000
-42.9%
1000.0%0.00%
-50.0%
Q1 2020$7,0000.0%1000.0%0.00%0.0%
Q4 2019$7,000
-50.0%
1000.0%0.00%
-60.0%
Q3 2019$14,000
-22.2%
1000.0%0.01%
-28.6%
Q2 2019$18,000
+12.5%
1000.0%0.01%0.0%
Q1 2019$16,000
+60.0%
1000.0%0.01%
+40.0%
Q4 2018$10,000100
+2400.0%
0.01%
Q4 2014$040.0%0.00%
Q3 2014$040.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders